Osiris Therapeutics, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
Published: Nov 21, 2012
COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 9:00 a.m. ET in New York City. A live webcast of the presentation may be accessed through the Investors page of the Company’s website at www.Osiris.com. A replay of the webcast will be available for one week following the conference.